Corrigendum: Combination therapy with fingolimod and neural stem cells promotes functional myelination

Authors

• Yuan Zhang
• Xin-Yu Lu
• Ze-Qin Ye
• Bogoljub Ciric
• Cun-Gen Ma
• Abdolmohamad Rostami
• Xing Li
• Guang-Xian Zhang

Publication/Presentation Date

1-1-2022

Abstract

[This corrects the article DOI: 10.3389/fncel.2019.00014.].

Volume

16

First Page

1022297

Last Page

1022297

ISSN

1662-5102

Published In/Presented At

Zhang, Y., Lu, X. Y., Ye, Z. Q., Ciric, B., Ma, C. G., Rostami, A., Li, X., & Zhang, G. X. (2022). Corrigendum: Combination therapy with fingolimod and neural stem cells promotes functional myelination in vivo through a non-immunomodulatory mechanism. Frontiers in cellular neuroscience, 16, 1022297. https://doi.org/10.3389/fncel.2022.1022297

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

36589285

Department(s)

Administration and Leadership

Document Type

Article